506 related articles for article (PubMed ID: 11685115)
1. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
[TBL] [Abstract][Full Text] [Related]
2. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
J Immunol; 2001 May; 166(9):5619-28. PubMed ID: 11313402
[TBL] [Abstract][Full Text] [Related]
3. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
Sayegh MH; Akalin E; Hancock WW; Russell ME; Carpenter CB; Linsley PS; Turka LA
J Exp Med; 1995 May; 181(5):1869-74. PubMed ID: 7536798
[TBL] [Abstract][Full Text] [Related]
4. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
Qian S; Lu L; Fu F; Li W; Pan F; Steptoe RJ; Chambers FG; Starzl TE; Fung JJ; Thomson AW
Transplantation; 1998 Jun; 65(12):1590-8. PubMed ID: 9665075
[TBL] [Abstract][Full Text] [Related]
5. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
Lin H; Wei RQ; Goodman RE; Bolling SF
Surgery; 1997 Aug; 122(2):129-37. PubMed ID: 9288115
[TBL] [Abstract][Full Text] [Related]
6. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
7. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
8. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.
Reddy B; Gupta S; Chuzhin Y; Kalergis AM; Budhai L; Zhang M; Droguett G; Horwitz MS; Chowdhury JR; Nathenson SG; Davidson A
Transplantation; 2001 Mar; 71(6):801-11. PubMed ID: 11330546
[TBL] [Abstract][Full Text] [Related]
9. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection.
Morelli AE; O'Connell PJ; Khanna A; Logar AJ; Lu L; Thomson AW
Transplantation; 2000 Jun; 69(12):2647-57. PubMed ID: 10910289
[TBL] [Abstract][Full Text] [Related]
10. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425
[TBL] [Abstract][Full Text] [Related]
11. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
Schaub M; Stadlbauer TH; Chandraker A; Vella JP; Turka LA; Sayegh MH
J Am Soc Nephrol; 1998 May; 9(5):891-8. PubMed ID: 9596088
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
[TBL] [Abstract][Full Text] [Related]
14. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
[TBL] [Abstract][Full Text] [Related]
15. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts.
Glysing-Jensen T; Räisänen-Sokolowski A; Sayegh MH; Russell ME
Transplantation; 1997 Dec; 64(12):1641-5. PubMed ID: 9422395
[TBL] [Abstract][Full Text] [Related]
16. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
17. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
19. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
[TBL] [Abstract][Full Text] [Related]
20. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
Abrams JR; Kelley SL; Hayes E; Kikuchi T; Brown MJ; Kang S; Lebwohl MG; Guzzo CA; Jegasothy BV; Linsley PS; Krueger JG
J Exp Med; 2000 Sep; 192(5):681-94. PubMed ID: 10974034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
